{
  "id": 6340003,
  "title": "XORTX Re-Engages Investor Relations Program",
  "url": "https://urgent.news/2026/09/08/xortx-re-engages-investor-relations-program",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-08T22:16:47.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/xortx-re-engages-investor-relations-program"
  },
  "original_language": "en",
  "account": null,
  "summary": "CALGARY, Alberta, Sept. 08, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) announces that, following completion of its previously announced voluntary delisting from the TSX Venture Exchange, XORTX has re-engaged IR Agency LLC pursuant to a consulting agreement providing for investor relations and marketing services on substantially the same terms previously disclosed…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}